ENLOE J DAVID JR

USNatural personSenior VP

FrançaisSign in Try free 14d

Insider

ENLOE J DAVID JR

USNatural personSenior VP

Transactions

Issuers

Buys / Sells

14/0

Last tx

08 Apr 2024

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Recro Pharma, Inc.	1,865,246	reported	08 Apr 2024	tx 31+3,712,904−2,788,877
INTROGEN THERAPEUTICS INC	150,000	reported	16 May 2008	tx 14+582,400−239,843

Track record

Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 7 buys in history.

1 month

−0.9%

Sample6

Win rate (≥5%)17%

Hit rate (>0)50%

3 months

−7.8%

Sample5

Win rate (≥5%)20%

Hit rate (>0)40%

6 months

—

3 buys

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
08 Apr 2024	OTHER	Recro Pharma, Inc.	1,865,246	1.10 USD
08 Apr 2024	TENDER	Recro Pharma, Inc.	801,597	1.10 USD
29 Feb 2024	GRANT_AWARD	Recro Pharma, Inc.	1,371,429	0.00 USD
24 Jan 2024	GRANT_AWARD	Recro Pharma, Inc.	196,474	0.00 USD
28 Aug 2023	PURCHASE	Recro Pharma, Inc.	125,000	0.40 USD	anomaly
19 Jan 2023	TAX_WITHHOLDING	Recro Pharma, Inc.	56,985	1.35 USD
20 Jan 2023	TAX_WITHHOLDING	Recro Pharma, Inc.	31,046	1.36 USD
19 Jan 2023	GRANT_AWARD	Recro Pharma, Inc.	412,401	0.00 USD
19 Jan 2023	GRANT_AWARD	Recro Pharma, Inc.	151,515	—
19 Jan 2023	GRANT_AWARD	Recro Pharma, Inc.	287,374	0.00 USD	deriv
15 Dec 2022	TAX_WITHHOLDING	Recro Pharma, Inc.	11,413	1.33 USD
15 Nov 2022	PURCHASE	Recro Pharma, Inc.	660	1.71 USD
17 Oct 2022	PURCHASE	Recro Pharma, Inc.	625	1.69 USD
15 Sept 2022	PURCHASE	Recro Pharma, Inc.	714	1.41 USD
15 Aug 2022	PURCHASE	Recro Pharma, Inc.	757	1.26 USD
15 Jul 2022	PURCHASE	Recro Pharma, Inc.	1,150	0.81 USD
15 Jun 2022	PURCHASE	Recro Pharma, Inc.	1,562	0.68 USD
16 May 2022	PURCHASE	Recro Pharma, Inc.	1,086	0.96 USD
18 Apr 2022	PURCHASE	Recro Pharma, Inc.	625	1.63 USD
20 Jan 2022	TAX_WITHHOLDING	Recro Pharma, Inc.	22,590	1.65 USD
15 Mar 2022	PURCHASE	Recro Pharma, Inc.	512	1.96 USD
15 Feb 2022	PURCHASE	Recro Pharma, Inc.	571	1.77 USD
20 Jan 2022	GRANT_AWARD	Recro Pharma, Inc.	303,030	0.00 USD
20 Jan 2022	GRANT_AWARD	Recro Pharma, Inc.	66,007	—
20 Jan 2022	GRANT_AWARD	Recro Pharma, Inc.	442,478	0.00 USD	deriv